Dumont & Blake Investment Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,667
| Closed | -$235K | – | 189 |
|
|
2022
Q2 | $235K | Hold |
1,667
| – | – | 0.08% | 178 |
|
|
2022
Q1 | $232K | Hold |
1,667
| – | – | 0.06% | 195 |
|
|
2021
Q4 | $291K | Hold |
1,667
| – | – | 0.08% | 169 |
|
|
2021
Q3 | $276K | Sell |
1,667
-371
| -18% | -$63.9K | 0.08% | 169 |
|
|
2021
Q2 | $367K | Hold |
2,038
| – | – | 0.1% | 151 |
|
|
2021
Q1 | $393K | Hold |
2,038
| – | – | 0.12% | 144 |
|
|
2020
Q4 | $411K | Hold |
2,038
| – | – | 0.14% | 133 |
|
|
2020
Q3 | $428K | Hold |
2,038
| – | – | 0.16% | 122 |
|
|
2020
Q2 | $447K | Hold |
2,038
| – | – | 0.19% | 118 |
|
|
2020
Q1 | $353K | Hold |
2,038
| – | – | 0.18% | 121 |
|
|
2019
Q4 | $313K | Sell |
2,038
-1,900
| -48% | -$284K | 0.12% | 139 |
|
|
2019
Q3 | $598K | Buy |
3,938
+1,850
| +89% | +$292K | 0.25% | 108 |
|
|
2019
Q2 | $320K | Hold |
2,088
| – | – | 0.13% | 145 |
|
|
2019
Q1 | $335K | Buy |
2,088
+2
| +0.1% | +$310 | 0.14% | 139 |
|
|
2018
Q4 | $322K | Buy |
2,086
+2
| +0.1% | +$312 | 0.15% | 136 |
|
|
2018
Q3 | $313K | Buy |
2,084
+2
| +0.1% | +$284 | 0.12% | 147 |
|
|
2018
Q2 | $282K | Buy |
2,082
+2
| +0.1% | +$247 | 0.12% | 147 |
|
|
2018
Q1 | $277K | Buy |
2,080
+2
| +0.1% | +$269 | 0.12% | 145 |
|
|
2017
Q4 | $309K | Buy |
2,078
+2
| +0.1% | +$272 | 0.13% | 145 |
|
|
2017
Q3 | $274K | Buy |
2,076
+2
| +0.1% | +$269 | 0.12% | 147 |
|
|
2017
Q2 | $276K | Buy |
2,074
+1
| +0% | +$135 | 0.12% | 146 |
|
|
2017
Q1 | $279K | Buy |
2,073
+2
| +0.1% | +$259 | 0.13% | 149 |
|
|
2016
Q4 | $249K | Buy |
2,071
+2
| +0.1% | +$236 | 0.12% | 148 |
|
|
2016
Q3 | $259K | Buy |
2,069
+2
| +0.1% | +$262 | 0.13% | 144 |
|
|
2016
Q2 | $286K | Buy |
2,067
+1
| +0% | +$130 | 0.14% | 139 |
|
|
2016
Q1 | $260K | Buy |
2,066
+2
| +0.1% | +$254 | 0.13% | 136 |
|
|
2015
Q4 | $262K | Buy |
2,064
+2
| +0.1% | +$248 | 0.13% | 142 |
|
|
2015
Q3 | $238K | Buy |
2,062
+2
| +0.1% | +$225 | 0.13% | 136 |
|
|
2015
Q2 | $214K | Buy |
2,060
+2
| +0.1% | +$216 | 0.1% | 136 |
|
|
2015
Q1 | $227K | Buy |
2,058
+1
| +0% | +$109 | 0.11% | 133 |
|
|
2014
Q4 | $214K | Sell |
2,057
-64
| -3% | -$6.4K | 0.11% | 134 |
|
|
2014
Q3 | $204K | Buy |
+2,121
| New | +$192K | 0.11% | 140 |
|
Other funds holding CLX
Dumont & Blake Investment Advisors's CLX Position: Q3 2022 in Review
Dumont & Blake Investment Advisors sold out of Clorox (CLX) in Q3 2022, closing a stake of 1,667 shares — an estimated $235K sold.
Dumont & Blake Investment Advisors first reported a position in CLX in Q3 2014 and held it in 32 quarters. The position peaked at $598K in Q3 2019. 1,045 funds tracked by Wall St. Rank hold CLX as of Q3 2022.
- Dumont & Blake Investment Advisors reported no remaining Clorox position as of Q3 2022 after selling out during the quarter.
- Dumont & Blake Investment Advisors sold 1,667 Clorox shares in Q3 2022, an estimated $235K.
- Dumont & Blake Investment Advisors first reported a position in Clorox in Q3 2014 and held it in 32 quarters.
- Dumont & Blake Investment Advisors's Clorox position peaked at $598K in Q3 2019.
- 1,045 funds tracked by Wall St. Rank held Clorox as of Q3 2022.
Based on Dumont & Blake Investment Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.